Endocrine profiles in tamoxifen-induced conception cycles

Fertility and sterility, 42(4), 548-553

DOI 10.1016/s0015-0282(16)48137-9 PMID 6436061 Source

Abstract

Twenty-five infertile women conceived while taking tamoxifen (TMX). Daily serum profiles of 5 of the 25 TMX-induced conception cycles were elucidated and compared with those found in 5 normal cycles. In spite of lower levels of follicle-stimulating hormone and luteinizing hormone during the follicular phases, estradiol concentrations were higher in the TMX-induced conception cycles. It is suggested that this may be due to a direct ovarian effect of TMX as one of its major mechanisms in the course of folliculogenesis. On the other hand, progesterone concentrations on days 6 and 7 during the luteal phases were also higher in the TMX-induced conception cycles. It is suggested that this may be due to a luteotropic influence at the blastocyst stage.

Topics

androgens breast cancer risk premenopausal, progesterone breast cancer protection, testosterone breast cancer premenopausal women, luteal phase progesterone breast cancer, low progesterone breast cancer risk, androgen excess breast cancer, anovulation breast cancer risk, hormonal imbalance breast malignancy, progesterone deficiency breast disease, androstanediol breast cancer marker, serum testosterone breast cancer premenopausal, luteal phase hormone breast cancer

Cite this article

Tajima, C. (1984). Endocrine profiles in tamoxifen-induced conception cycles. *Fertility and sterility*, *42*(4), 548-553. https://doi.org/10.1016/s0015-0282(16)48137-9

Related articles